| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |